XML 85 R76.htm IDEA: XBRL DOCUMENT v3.25.2
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,593,895   $ 2,593,895   $ 2,462,400
Total assets 5,721,165   5,721,165   5,487,962
Current liabilities 1,607,760   1,607,760   1,915,644
Total liabilities 3,099,554   3,099,554   2,953,473
Total joint venture equity 2,515,871   2,515,871   2,416,389
Investments in and advances to unconsolidated joint ventures 150,721   150,721   138,759
Revenue 1,584,323 $ 1,670,467 3,138,683 $ 3,206,143  
Costs 1,235,970 1,318,931 2,436,347 2,529,758  
Net income attributable to Parsons Corporation 55,230 69,172 121,433 108,922  
Equity in earnings of unconsolidated joint ventures (642) (16,837) (1,329) (18,897)  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 1,449,797   1,449,797   1,477,950
Noncurrent assets 447,725   447,725   431,476
Total assets 1,897,522   1,897,522   1,909,426
Current liabilities 960,893   960,893   947,072
Noncurrent liabilities 500,834   500,834   469,808
Total liabilities 1,461,727   1,461,727   1,416,880
Total joint venture equity 435,795   435,795   492,546
Investments in and advances to unconsolidated joint ventures 150,721   150,721   $ 138,759
Revenue 425,795 544,000 950,351 1,017,532  
Costs 391,301 555,971 912,177 1,032,721  
Net income attributable to Parsons Corporation 34,494 (11,971) 38,174 (15,189)  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Equity in earnings of unconsolidated joint ventures $ (642) $ (16,837) $ (1,329) $ (18,897)